Clin2
NCT07301632Possibly a fitRecruiting

MDMA for severe chronic nerve pain

Chronic Neuropathic Pain

Treatments studied

Part of Brain & nervous system, Pain clinical trials.

This trial tests if MDMA, combined with psychotherapy, can help people with severe chronic nerve pain that hasn't improved with standard treatments. You'll receive either MDMA or a placebo to see if it safely reduces pain and improves your quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have had nerve pain for more than 3 months, confirmed by a pain specialist.
  • Your pain is moderate to severe, with a PROMIS pain interference score of 60 or higher and average pain at least 5 out of 10.
  • You have tried at least 2 recommended nerve pain medications without meaningful improvement.
  • You are willing to use effective birth control if you could become pregnant, and you have sufficient English for therapy sessions.
  • You are not currently taking certain antidepressants, stimulants, or other medications that could interact with MDMA.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06731335Recruiting· Phase 2
Psilocybin for chronic nerve pain that hasn't improved with other treatments

This study tests whether psilocybin (a compound found in certain mushrooms) can help reduce chronic nerve pain that has not responded well to standard medications. You will receive study treatment plus psychotherapy to see if it improves your pain.

Toronto, Ontario
NCT06518720Recruiting· Phase 2
Psilocybin for Chronic Nerve Pain and Depression

This trial tests whether psilocybin (a psychedelic medication) can help people who have both chronic nerve pain and depression that hasn't responded to standard treatments. The goal is to see if it can reduce pain and improve mood.

Toronto, Ontario
NCT05285683Recruiting· Phase 2
Study brain dopamine in people with chronic pain

This Phase 2 study looks at how a brain chemical called dopamine is involved in long-lasting pain. You may be able to join if you have chronic pain for over a year and your pain score is high enough, and if MRI and health checks are safe for you.

Rochester, New York
NCT07494214Recruiting· Phase 1
Study on MDMA for pain relief in healthy people

This trial tests if a single dose of MDMA can reduce pain caused by heat or pressure in healthy volunteers. It aims to see if MDMA might help with certain types of pain that are hard to treat.

Basel
NCT06066853Recruiting· Early Phase 1
MDMA plus therapy for fibromyalgia pain

This trial tests whether MDMA (a drug sometimes called 'ecstasy') can help people with fibromyalgia when used alongside therapy sessions. The goal is to see if it reduces pain and improves quality of life.

Charlestown, Massachusetts
NCT06954025Enrolling by invitation· Phase 2
MDMA therapy for PTSD inpatients

This trial tests whether high-dose MDMA, given during intensive inpatient therapy, can help people with PTSD that hasn't improved with other treatments. It takes place at a specialized trauma center and involves several therapy sessions with the drug.

Oegstgeest

Hear when a new Chronic Neuropathic Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.